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Although numerous approaches have been developed to map RNA-binding sites of individual RNA-binding proteins
(RBPs), few methods exist that allow assessment of global RBP–RNA interactions. Here, we describe PIP-seq, a universal,
high-throughput, ribonuclease-mediated protein footprint sequencing approach that reveals RNA-protein interaction
sites throughout a transcriptome of interest. We apply PIP-seq to the HeLa transcriptome and compare binding sites
found using different cross-linkers and ribonucleases. From this analysis, we identify numerous putative RBP-binding
motifs, reveal novel insights into co-binding by RBPs, and uncover a significant enrichment for disease-associated
polymorphisms within RBP interaction sites.Background
RNA–protein interactions are central to all of the post-
transcriptional regulatory processes that control gene
expression. From the initial processing of a protein-coding
transcript in the nucleus to its final translation and decay
in the cytoplasm, cellular mRNAs are involved in a complex
choreography with various transacting RNA-binding
proteins (RBPs) [1-3]. RBPs are also required for the
processing and function of the thousands of non-coding
RNAs (ncRNAs), both large and small, encoded by
eukaryotic genomes. These RNAs have a variety of cellular
functions, including chromatin regulation and control of
cell fate [4,5]. Thus, RNA–protein interactions represent a
vast, diverse and critical layer of transcriptome regulation.
Eukaryotic genomes encode a large collection of RBPs that
interact with mRNAs to form dynamic multi-component
ribonucleoprotein complexes (mRNPs) [6,7]. These mRNPs
often constitute the functional forms of mRNAs, and it
is only through their proper formation that transcripts
are correctly regulated to produce the precise required* Correspondence: bdgregor@sas.upenn.edu
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reproduction in any medium, provided the oramounts of each protein in a cell [2,3,7,8]. Intriguingly,
recent evidence suggests that post-transcriptional regula-
tion of mRNAs encoding functionally related proteins likely
requires mRNP assembly by specific sets of co-occurring
RBPs, an idea that was originally postulated by the post-
transcriptional operon hypothesis [9,10]. Thus, the precise
composition and formation of RNPs in eukaryotic cells is
critical for proper gene expression regulation.
The essential nature of RNA–protein interactions in
eukaryotic biology has led to numerous biochemical, gen-
etic and computational approaches being utilized, alone
and in combination, to identify and validate RBPs and their
specific RNA-binding sites [1,11,12]. These approaches
have proven useful in characterizing a number of RBPs
[13-26]. However, all of these earlier approaches investi-
gated RNA–protein interactions one protein at a time,
which limited their ability to monitor the global landscape
of RNPs and reveal insights into the combinatorial binding
and regulation by the cellular milieu of RBPs. Thus,
there is a major gap between the significance of cellular
RNA–RBP interactions and the difficulty in establishing a
comprehensive catalogue of these interactions in a single
experiment.
Recently, several groups have established experimental
approaches for interrogating RNA–protein interaction
sites on a more global scale. These approaches utilizeral Ltd. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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tein interactions by uncovering sites of T > C transversion
(representing RNA–protein cross-linking events) [27,28].
However, these studies have been limited by several
factors. Specifically, they rely on treatment with synthetic
nucleotides and UV cross-linking, which can be used
for cell cultures but not tissues or whole organisms.
Furthermore, UV cross-linking only identifies sites of
direct RNA–protein contact and may not capture the
larger multi-protein complexes that make up the overall
RNP architecture in vivo. Finally, these studies have focused
on poly-adenylated (polyA) transcripts, reducing their
ability to monitor RBP binding in non-polyA and nascent
RNAs.
To address the limitations of the currently available
methodologies, we present a ribonuclease (RNase)-mediated
protein footprint sequencing approach that we call protein
interaction profile sequencing (PIP-seq). This approach
identifies RNA–protein interaction sites within both
unprocessed and mature RNAs in a mostly unbiased
manner and on a transcriptome-wide scale. We describe
multiple cross-linking techniques to capture both direct
and indirect RNA–protein interactions. We also show that
both single-stranded and double-stranded RNases uncover
distinct but overlapping sets of RNA–protein interaction
sites. Using this approach, we find PIP-seq to be a repro-
ducible approach that reveals both previously known and
novel RBP interaction sites. We demonstrate the utility of
PIP-seq by uncovering enriched sequence motifs within
the complement of identified RBP interaction sites. We
also investigate the interactions among protein-binding
sites and provide evidence for co-binding of RNAs by
specific sets of RBPs, some of which bind to groups of
transcripts encoding functionally related proteins. These
results reveal novel insights into networks of post-
transcriptional gene regulation mediated by specific groups
of RBP-bound sequence motifs. Finally, we identify a
significant enrichment for disease-associated variants
within RBP interaction sites, and demonstrate the effects
of some of these single nucleotide polymorphisms (SNPs)
on RNA–protein interactions. Overall, our approach pro-
vides an RNA-centric global assessment of RNA–RBP in-
teractions that directly identifies RNA–protein interaction
sites and is applicable for all organisms and sample types.
Results and discussion
An RNase-mediated protein footprint sequencing
approach that identifies sites of RNA–protein interaction
To obtain an unbiased, genome-wide view of RNA–protein
interactions for both unprocessed and mature RNAs
in eukaryotic transcriptomes, we developed an RNase-
mediated protein footprint sequencing approach, known
as PIP-seq, by performing nuclease-sensitivity sequencing
assays [29,30] on cross-linked RNA–protein complexesfrom HeLa cells (Figure 1A). Previous investigations of
RNA–protein interactions have assayed stable endogenous
interactions as well as those captured by UV (254 nm),
which cross-links only direct protein–nucleic acid contacts,
and formaldehyde, which cross-links protein–nucleic acid
and protein–protein contacts with a longer range [31-33].
Therefore, to generate a comprehensive and multifaceted
view of RBP interaction sites, we used both cross-linking
techniques and no cross-linking when performing PIP-seq.
We had previously used nuclease-sensitivity sequencing
assays on purified RNAs to determine RNA base-pairing
probabilities by treating RNA with either single-stranded
or double-stranded RNase (ss- or dsRNase, respectively)
and sequencing the resulting populations [29,30]. We
reasoned that by using both of these RNases on cross-
linked RNA–protein complexes, we would be able both to
map RBP-binding sites comprehensively and also to inves-
tigate RNA base-pairing probabilities in vivo. However, for
the purposes of this manuscript we focus our analysis spe-
cifically on the identification of protein-interaction sites,
which we refer to as protein-protected sites (PPSs).
To perform PIP-seq, we started with adherent HeLa
cells cross-linked by one of the methods described above
(UV or formaldehyde) or used cells that had not been
cross-linked. The resulting cell lysates were then split
into experimental and background samples. Due to the
structure-specific nature of the RNases used, it was
essential to have a background sample to control for
RNase insensitive regions. Therefore, a ‘footprint sample’
(experimental) was directly treated with either a single-
stranded RNase (ssRNase), known as RNaseONE, or
double-stranded RNase (dsRNase), known as RNaseV1.
In contrast, the RNase digestion control sample was
first denatured in SDS and treated with proteinase K
prior to RNase digestion. In this way, regions that were
protein-protected in the footprint sample became sensi-
tive to RNase digestion in the control sample and regions
that were unbound but insensitive to one of the nucleases
due to their structural status, remained that way. For
both samples, cross-links were subsequently reversed
(by heating for formaldehyde cross-links or by extensive
proteinase K treatment for UV cross-links), which was
followed by strand-specific library preparation (Figure 1A).
Highly abundant RNA species (for example, ribosomal
RNAs) were depleted from each library based on their rapid
re-annealing rates using a thermostable duplex-specific
nuclease (DSN) protocol (see Materials and methods for
more details).
We then sequenced the resulting libraries (four in total
for each replicate) using the Illumina 50-bp single-end
sequencing protocol, and obtained approximately 31 to
60 million raw reads per library (Additional file 1). To
identify PPSs, we used a Poisson distribution model
based on a modified version of the CSAR software package
Figure 1 Overview of the PIP-seq method. (A) In the PIP-seq method, cells are cross-linked with formaldehyde or 254-nm UV light, or not cross-linked.
They are lysed and divided into footprint and RNase digestion control samples. The footprint sample is treated with an RNase (ss- or dsRNase), which
results in a population of RNase-protected RNA–RBP complexes. The protein cross-links are then reversed (by heating for formaldehyde cross-links or
by proteinase K treatment for UV cross-links), leaving only the footprints where the RNA was protein-bound. For the RNase digestion control sample,
which is designed to control for RNase insensitive regions, the order of operations is reversed; bound proteins are first removed by treatment with SDS
and proteinase K, and then the unprotected RNA sample is subjected to RNase treatment. Strand-specific high-throughput sequencing libraries are
prepared from both footprint and RNase digestion control samples and normalized using rehybridization and duplex-specific nuclease (DSN)
treatment. PPSs are identified from the sequencing data using a Poisson model. Screenshots show UCSC browser views of sequencing reads
from the footprint and RNase digestion control sample (same scale) and PPSs identified from the regions of the genes listed. (B,C) Absolute
distribution of PPSs throughout RNA species for formaldehyde (B) and UV (C) cross-linked PIP-seq experiments. (D,E) Average PPS count per RNA
molecule (classified by RNA type (mRNA and lncRNA) and transcript region (for example, 5′ UTR)) for formaldehyde (D) and UV (E) cross-linked PIP-seq
experiments. Percentages indicate the fraction of each RNA type or region that contains PPS information. (F) Average expression (y-axis) of human
mRNAs separated by total number of PPSs identified in their sequence (x-axis) for PPSs identified using formaldehyde cross-linking. CDS, coding
sequence; DSN, duplex-specific nuclease; dsRNase, double-stranded RNase; lncRNA, long non-coding RNA; PIP-seq, protein interaction profile
sequencing; PPS, protein-protected site; ssRNase, single-stranded RNase; UTR, untranslated region.
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base position in the genome and a Poisson test was used
to compute an enrichment score for the footprint versus
RNase digestion control libraries (Additional file 1). PPSs
were then called as described for ChIP-seq analysis [34]
with a false discovery rate (FDR) of 5% (Figure 1A; for
more examples see Additional file 2A to E). Using thisapproach we identified a total of approximately 1,011,000
PPSs over seven experiments, comprising approximately
430,000 non-overlapping sites (Additional file 1). Of note,
saturation analysis indicated near linear growth in the
number of PPSs relative to read depth, suggesting that fur-
ther sequencing would likely uncover more PPSs, but with
diminishing returns (Additional file 2F).
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and with no cross-linking to be widely distributed across
both exonic and intronic regions, with a particular enrich-
ment for distal intronic binding in the formaldehyde-
cross-linked experiments (Figure 1B,C and Additional
file 3A). Closer examination of PPSs broken down by genic
features (for example, 5′ and 3′ UTRs, coding sequence
(CDS) and intron) or RNA type (mRNA and long non-
coding RNA (lncRNA)) revealed that >50% of all human
mRNAs contained multiple binding events across all
transcript regions except 5′ UTR (average of approximately
1 PPS in only 28.8% of total transcripts) in HeLa cells
(Figure 1D,E and Additional file 3B). Strikingly, an average
of approximately 26 PPSs was found in the introns of each
transcript in the formaldehyde-cross-linked PIP-seq
experiments, compared with approximately three and
approximately two intronic PPSs with the UV-cross-
linked and non-cross-linked experiments, respectively
(Figure 1D,E and Additional file 3B). These results suggest
that formaldehyde cross-linking captures more transient
and/or weak RBP–RNA interactions within intronic,
especially distal (>500 nucleotides from a splice site),
portions of mRNAs. We also found that approximately 2%
to 6% of all known human lncRNAs could be identified as
containing an average of 2.5 PPSs in HeLa cells using PIP-
seq with the various cross-linking strategies (Figure 1D,E
and Additional file 3B). The limited number of PPS-
containing lncRNAs uncovered by our experiments is likely
due to the low expression and tissue-specific nature of
these transcripts. To address a possible dependence of our
approach on RNA expression levels, we assessed the rela-
tion between RNA steady-state abundance and the number
of PPSs per transcript and found that RNA levels explained
only a small fraction (R2 = 0.11) of the total variation in PPS
counts between transcripts (Figure 1F and Additional file
3C,D). Overall, these results suggest that PIP-seq provides a
comprehensive and mostly unbiased view of global RNA–
protein interaction sites in eukaryotic transcriptomes.
In general, we found that formaldehyde cross-linking
revealed the highest number of PPSs, whereas UV and no
cross-linking yielded many fewer sites (Additional file 1).
This is not surprising, given that formaldehyde both has a
longer range than UV and can also stabilize more transient
and indirect interactions. Thus, the use of formaldehyde
cross-linking gives a more comprehensive view of RNA–
protein interaction sites, while the use of UV likely in-
creases the specificity of PPSs to more tightly associated
RBP-bound targets. We also observed that ssRNase treat-
ment yielded twice as many unique PPSs compared to
dsRNase digestion (Additional file 1). There are several
explanations for this, none of which are mutually exclusive.
For example, the ssRNase may have higher activity in the
reaction conditions used in our experiments, the dsRNase
may have lower accessibility to protein-bound dsRNAregions, or human RBPs may prefer non-structured regions
within target RNAs for interaction. Together, these results
show that the choice of cross-linking reagent or RNase
can have a profound effect on RNA–protein interaction
site identification and that these effects likely apply to the
other technologies that address this same experimental
question [27,28].
PIP-seq is a reproducible approach for identifying known
and novel RBP interaction sites
To assess the reproducibility of PIP-seq, we first deter-
mined the correlation of sequencing read abundance
between biological replicates of footprint and RNase
digestion control libraries (Figure 2A,B and Additional
file 4). Using a sliding-window approach, we observed
a high correlation in read counts between individual
replicates of formaldehyde-cross-linked ssRNase-treated
footprint and RNase digestion control libraries (Pearson
correlation r = 0.88 and 0.84, respectively) (Figure 2A and
Additional file 4A,B). Similar results were also found for
the dsRNase-treated libraries (Pearson correlation r = 0.84
and 0.76, footprint and RNase digestion control, respect-
ively) (Figure 2B and Additional file 4A,B). This high
reproducibility of PIP-seq libraries was also observed be-
tween replicates of the UV-cross-linked libraries (Additional
file 4C). Together, these data indicate that PIP-seq experi-
ments and controls are reproducible across replicates using
various RNases and cross-linkers.
We next investigated the reproducibility of exact PPS
identification between paired biological replicates. With
formaldehyde cross-linking, we observed a 68% and 42%
(for ssRNase and dsRNase, respectively) overlap between
PPSs identified in two replicates (Figure 2C and Additional
file 5A). Similarly, 73% and 64% (ssRNase and dsRNase,
respectively) of the PPSs identified by UV cross-linking
were replicated in a second larger dataset (Additional
file 5B). This degree of overlap between PPSs is relatively
high when compared to the more modest reproducibility
of the identified RBP-binding sites in cross-linking and
immunoprecipitation sequencing (CLIP-seq) and photoac-
tivatable ribonucleoside cross-linking and immunoprecipi-
tation (PAR-CLIP) experiments [18]. In total, these results
indicate that our novel approach is a reproducible means of
identifying the protein-bound component of the eukaryotic
transcriptome.
We also interrogated the relation between PPSs identified
by different RNases. We compared RNaseONE, which
preferentially cleaves single-stranded RNA, to RNaseV1,
which preferentially cleaves paired bases (Additional
file 5C,D,E). We found a high overlap between formalde-
hyde-cross-linked PPSs (72%) identified by each RNase,
compared to UV-cross-linked (32%) or non-cross-linked
(37%) PPSs (Additional file 5C,D,E). This is unsurprising,
given the larger number (Additional file 1) of PPSs
Figure 2 PIP-seq is reproducible and captures known RBP–RNA interactions. (A) Correlation in read counts between two formaldehyde-cross-linked
ssRNase-treated PIP-seq replicates (footprint sample on left, RNase digestion control on right). (B) As (A), but for formaldehyde-cross-linked dsRNase-treated
replicates. (C) Overlap in PPS calls between formaldehyde-cross-linked ssRNase-treated (top, blue), and formaldehyde-cross-linked dsRNase-treated
(bottom, green) PIP-seq replicates. (D) Overlap between PPSs identified from three formaldehyde-treated PIP-seq samples and various CLIP datasets.
Values are shown as log2 enrichment over shuffled background distributions. *** denotes P < 2.2 × 10
-16 (chi-squared test). (E) Overlap between
formaldehyde-cross-linked PPSs from HeLa cells and 40-nucleotide T > C transversion event-containing loci from the gPAR-CLIP dataset generated from
HEK293T cells (T > C transversion events less than 40 bp apart were merged to generate a dataset comparable to PPSs). (F) Number of T > C transversion
events per PPS identified by formaldehyde cross-linking (purple) versus shuffled regions (gray). Values for the number of events per shuffled region are the
average from ten random shuffles. bp, base pair; dsRNase, double-stranded RNase; PIP-seq, protein interaction profile sequencing; PPS, protein-protected
site; ssRNase, single-stranded RNase.
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to UV-cross-linked or non-cross-linked experiments. In
total, these results revealed that both RNases uncovered a
set of overlapping and unique PPS sequences, demonstrat-
ing that an ss- and dsRNase are needed for comprehensiveidentification of RNA–protein interaction sites in eukaryotic
transcriptomes.
To validate that PIP-seq identifies bona fide RNA–protein
interaction sites, we overlapped PPSs with known RBP-
binding sites from HeLa and HEK293T cells [14-27], and
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the exception is one HuR dataset for UV-cross-linked
PPSs; see Additional file 6A) of the PPSs coincided with
numerous RPB interaction sites previously tested by single
protein immunoprecipitation approaches (for example,
HITS-CLIP, PAR-CLIP and so on) compared to an
expressed transcriptome background (see Materials and
methods for more details) (Figure 2D and Additional file
6A,B). This is noteworthy given our analysis of PPSs in
HeLa cells, since the majority of the CLIP-seq and PAR-
CLIP datasets were generated using HEK293T cells.
We also compared our data with previously published
global PAR-CLIP (gPAR-CLIP) data from HEK293T cells
[27], in which protein-binding sites were identified on the
basis of T > C transversions (Figure 2D,E and Additional
file 6A,B,C,D). We observed a significant (P < 2.2 × 10–16)
enrichment of the previously identified transversion events
within our identified PPSs relative to the expressed
transcriptome background, suggesting that at least some
fraction of binding events are cell-type independent (there
was an approximately 38% overlap between HeLa and
HEK293T cells, Figure 2D,E and Additional file 6A,B,C,D).
Furthermore, we analyzed the number of T > C trans-
versions per PPS and found that on average 6.3 T > C
transversions were observed per PPS for the formaldehyde-
cross-linked PPSs (Figure 2F and Additional file 6E,F).
These data revealed that there are often numerous
gPAR-CLIP T > C transversions per RNA–protein-binding
event identified by PIP-seq, and suggest that many of our
identified PPSs are sites of multi-RNA-binding domain
(RBD) and/or multi-RBP interactions. Additionally, our
findings demonstrate that PIP-seq can identify the full
footprint of RBP–RNA interaction sites, underscoring its
utility in studying these events.
It is also worth noting that PIP-seq identified a total
of 428,713 of approximately 40-nucleotide-long protein-
protected regions, while gPAR-CLIP yielded 706,586 loci of
similar length (Figure 2E). There are multiple explanations
for this discrepancy. For instance, PIP-seq uses a back-
ground control library (RNase digestion control (Figure 1A))
whereas gPAR-CLIP does not. This control is likely im-
portant for distinguishing between noise and true protein-
binding events, and may account for the identification of
fewer sites by PIP-seq. Alternatively, PIP-seq may be
less sensitive due to the lack of a stringent RNA–protein
purification step. In total, our results indicate that PIP-seq
captures a significant population of human RNA–protein
interaction regions in a single experiment, further validating
its reliability and robustness.
PIP-seq gives an in-depth view of the protein-bound
transcriptome
Two outstanding questions in RNA biology are the extent
and patterning of RBP binding across genic regions. Weset out to address these questions using PIP-seq data from
the various cross-linkers and RNases. We first determined
the size distribution of PPSs identified using each RNase
and cross-linker (Figure 3A). We found that the median
PPS sizes for formaldehyde-cross-linked ss- and dsRNase
treatments were approximately 40 and approximately 35
nucleotides, respectively. Importantly, this variation in size
between the two RNases was consistent across cross-linkers
(Additional file 7A,B), suggesting that ssRNase treatment
reveals larger protein footprints and/or longer stretches of
RBP interactions across RNA regions.
To assess the genomic distribution of protein-binding
events, we calculated the enrichment of PPSs in specific
regions of the human transcriptome (for example, CDS, 5′
UTR, 3′ UTR, intron and so on) relative to their expression
levels in the RNase digestion control sample (Figure 3B and
Additional file 7C,D). This analysis revealed a consistent
enrichment between RNases and cross-linkers for protein-
binding in the 3′ UTR, proximal (<500 nucleotides from a
splice site) introns, as well as within the CDS (Figure 3B
and Additional file 7C,D). These results are unsurprising
given the role of these regions in post-transcriptional
regulation and translation. We also found that distal
(>500 nucleotides from a splice site) intronic regions were
enriched for protein binding in the formaldehyde-treated
samples only (Figure 3B), suggesting a high level of transi-
ent, weak and/or non-specific RNA-binding activity occurs
in these non-coding areas. Our results support the idea
that the large interior regions of introns may serve as sinks
for RBPs in human cells [19].
In contrast to protein-coding mRNAs, we found that
lncRNAs were consistently depleted for protein binding
(Figure 3B and Additional file 7C,D). Therefore, we closely
examined protein binding to the 100 most highly expressed
lncRNAs compared to expression-matched mRNA 3′
UTRs in the three different cross-linking conditions. These
analyses revealed that the fraction of identified lncRNA
and 3′ UTR base pairs bound by proteins was similar for
the formaldehyde cross-linking experiments using both
RNases. Conversely, for UV and no cross-linking, lncRNAs
were significant depleted in protein binding compared to
the expression-matched mRNA 3′ UTRs (Additional
file 7E). This depletion was consistent for both RNases,
suggesting that this finding is not a consequence of
structural differences between mRNAs and lncRNAs. In
total, these results support the hypothesis that lncRNAs
are more weakly and/or transiently bound by interacting
proteins compared to protein-coding mRNAs, which may
be a distinguishing feature of these two types of eukaryotic
RNAs.
Given the fundamental role of RBP–RNA interactions in
the regulation of eukaryotic gene expression, we hypothe-
sized that many of the identified PPSs are evolutionarily
conserved within vertebrates. To test this, we compared
Figure 3 Functional analysis and characterization of protein-binding sites. (A) Distribution of ssRNase-treated (light blue bars) and
dsRNase-treated (green bars) PPS sizes from formaldehyde-cross-linked samples. Dashed lines represent median PPS sizes (ssRNase, blue
line and dsRNase, green line). (B) Genomic distribution of PPS density, measured as PPS base coverage normalized to RNase digestion
control read counts per genomic region. Proximal intron refers to 500 nucleotides at the 5′ and 3′ ends of introns. (C) Cumulative
distribution of average SiPhy-π scores in PPSs (red line) versus similarly sized flanking sequences (gray line). (D) Comparison of average
SiPhy-π scores between PPSs (red bars) and flanking sequences (gray bars) for various genomic regions. (E) Average SiPhy-π score
profiles across the first and last 25 nucleotides of PPSs as well as 50 nucleotides upstream and downstream of exonic (green line),
intronic (blue line) and lncRNA (orange line) PPSs. *** denotes P < 2.2 × 10–16 (chi-squared test). CDS, coding sequence; dsRNase,
double-stranded RNase; lncRNA, long non-coding RNA; NS, not significant; PPS, protein-protected site; ssRNase, single-stranded RNase;
UTR, untranslated region.
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neighboring regions (Figure 3C,D,E, and Additional file 8).
Using this approach, we found that PPS sequences were
significantly (P < 2.2 × 10–16) more evolutionarily conserved
than flanking regions (Figure 3C and Additional file 8A,B).
Importantly, this was true for PPS sequences in both ex-
onic and intronic portions of human mRNAs, but not for
lncRNAs (Figure 3D,E), and was consistent for PPSs identi-
fied with every cross-linking approach (Figure 3D,E and
Additional file 8C,D,E,F). These results support the notion
that the ability to interact with RBPs is functionally import-
ant to mRNA sequences, and that this trait has undergone
selection during vertebrate evolution. Furthermore, the
lack of conservation of PPSs within lncRNAs is consistent
with their low conservation rates across vertebrate species.RBP-binding densities across unprocessed and
mature mRNAs
Given the importance of RBP binding within different
regions of mRNAs, we decided to determine the density
of protein-binding sites within specific regions of protein-
coding transcripts (Figure 4 and Additional file 9). To do
this, we first identified PPSs within each annotated CDS,
5′ UTR, 3′ UTR, and intronic region and calculated the
relative distribution of binding sites across these regions
(Figure 4A,B and Additional file 9A). We corrected for
the average length of each region to obtain a global view
of relative binding between regions. We also calculated
PPS coverage on a per nucleotide basis for specific subre-
gions of protein-coding mRNAs (Figure 4C,D,E,F, and
Additional file 9B,C).
Figure 4 The landscape of protein-binding site density. (A,B) Average PPS density for formaldehyde (A) and UV (B) cross-linking experiments
across 100 equally spaced bins in various genic regions. Values are normalized separately for each genic region (for example, intron). (C,D) Average
PPS density for formaldehyde (C) and UV (D) cross-linking experiments within 50 nucleotides of CDS ends. (E,F) Average PPS density for formaldehyde
(E) and UV (F) cross-linking experiments within the first and last 50 nucleotides of introns. Dotted lines in (C,D,E,F) represent the remaining
(unanalyzed) length of each element. CDS, coding sequence; PPS, protein-protected site; UTR, untranslated region.
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dehyde cross-linking, we observed similarly high levels
of binding within the entirety of the CDS and 3′ UTR of
protein-coding transcripts with an enrichment for binding
events occurring at and near the start and stop codons
(Figure 4A,C). This enrichment was particularly evidentwhen interrogating the PPS density over the start and stop
codons on a per nucleotide basis (Figure 4C). Similar en-
richments leading to the start of the CDS were identified
when defining PPS densities in the 5′ UTR. We also found
that the overall protein-binding density was lower in the
5′ UTR compared to the CDS and 3′ UTR (Figure 4A).
Silverman et al. Genome Biology 2014, 15:R3 Page 9 of 16
http://genomebiology.com/2014/15/1/R3The observed enrichment of PPSs at the CDS start and
stop codon regions likely reflects ribosome binding, as was
previously observed by others [27,28].
Overall similar patterns of RBP binding were also
observed for the UV-cross-linking and no-cross-linking
experiments (Figure 4B and Additional file 9A). The two
exceptions were that UV-cross-linked and non-cross-linked
RBP-binding densities across the 3′ UTR peaked near the
middle of this region (Figure 4B and Additional file 9A),
and the interaction profile directly over the start codon
displayed a minor depletion in protein binding in these
experiments (Figure 4D and Additional file 9B). These re-
sults likely reflect the differential cross-linking specificities
of formaldehyde and UV, and support the use of multiple
cross-linkers in the comprehensive identification of RBP-
binding sites.
Given the ability of PIP-seq to capture unprocessed
RNAs, we also investigated RBP-binding density across
introns. Unsurprisingly, we observed most binding events
proximal to the 5′ and 3′ splice sites (Figure 4A,B and
Additional file 9A). This was consistent across cross-linkers
and is likely due to extensive association with the lariat
formation machinery proximal to the splice sites. At single-
base resolution, we located the beginning of this enrich-
ment starting 40 nucleotides away from each splice site,
consistent with the binding location of RNA splicing
factors (Figure 4E,F and Additional file 9C). In total, our
results indicate that PIP-seq gives a comprehensive view
of RNA–protein interaction site densities in all portions
of mature as well as unprocessed mRNAs, especially when
multiple cross-linking agents are employed.
PIP-seq uncovers known and novel RNA–protein
interaction motifs and provides evidence for the
post-transcriptional operon hypothesis
Given that PPSs correspond to protein-bound RNA se-
quences (Figure 2), we sought to gain insights into the
sequence elements that are enriched within RNA–protein
interaction sites in the HeLa transcriptome. To do this, we
employed the MEME (Multiple EM for Motif Elicitation)
algorithm [35] on PPSs partitioned by specific region
(for example, 5′ UTR, 3′ UTR, CDS and intron). Because
we could not rule out ribosome binding at start and stop
codons, we additionally removed the first and last exons
of each CDS. Using this approach, we identified previously
known binding motifs including sequences similar to the
LIN28 binding motif [24] and U-rich sequences (Additional
file 10). We also identified numerous putative RBP-binding
motifs, some of which are particularly interesting because
they are long (approximately 20 nucleotides) and contain
multiple strong consensus sequences flanked by weaker
ones (3′ UTR motifs 4 and 31 and intron motifs 1 and 13)
(Additional file 10). These motifs may correspond to bind-
ing by multiple RNA-binding domains (for example, RRM)of a single protein or by a complex of multiple RBPs.
Importantly, motifs with this signature have not been
previously reported in CLIP-seq and PAR-CLIP data. In
addition, we identified at least one sequence that displayed
a high degree of self-complementarity (3′ UTR motif 1).
This is surprising, given that MEME does not use RNA
secondary structure as a search feature when identifying
motifs from a set of given sequences. These findings
underscore the utility of PIP-seq and its use of multiple
structure-specific nucleases to uncover hidden features
of the protein-interacting transcriptome.
Although RNAs are thought to be bound and regulated
by multiple RBPs, very little is known about these interac-
tions and the relations between specific RBPs and their
corresponding sequence motifs. To address this, we inter-
rogated the interactions between putative RBP-binding
motifs (Figure 5A) discovered by our PIP-seq approach,
since these are protein-bound sequences in HeLa cells.
To do this, we first identified all instances of each motif
within the global set of identified PPSs on target RNAs
using FIMO [36]. We collapsed motifs with similar se-
quences and excluded those that were long (approximately
20 nucleotides) and non-degenerate because these likely
represent repetitive sequences instead of true binding
motifs. We then quantified the co-binding of the remaining
motifs (approximately 40) within all protein-coding
mRNAs by counting the number of transcripts on
which each pair of motifs was jointly found within
PPSs. We then used k-means clustering of the resultant
weighted adjacency matrix and identified five clusters
of motifs that interact on highly similar sets of target
mRNAs (Figure 5A). These findings indicate that many
mRNAs contain numerous RBP-interacting motifs within
their sequences and that coordinated binding of RBPs
to specific target transcripts may represent a general
phenomenon of cellular RNA–protein interactions, as was
previously proposed by the post-transcriptional operon
hypothesis [9,10].
We also used DAVID [37] to interrogate over-represented
biological processes for RNAs that contained binding
events for each motif from the five clusters identified in
the k-means analysis (Figure 5A, Clusters 1, 3 to 5). It is
of note that the motifs in Cluster 2 did not co-occur in
a large enough group of bound transcripts to allow
meaningful gene ontology (GO) analysis. We found that
the most highly over-represented functional terms for
the RNAs that contained these co-occurring sequence
motifs in HeLa Clusters 1, 3 to 5 were related to distinct
processes, including developmental processes and immun-
ity (Cluster 1), caspase activity and apoptosis (Clusters 4
and 5, respectively), as well as regulation of transcription
and RNA metabolic processes (Cluster 3) (Figure 5B).
These results suggest that there are distinct groups of
RBP recognition motifs that are involved in the post-
Figure 5 PIP-seq uncovers protein-bound sequence motifs that co-occur in groups of functionally related transcripts. (A) MDS analysis
of RBP-bound motif co-occurrence in human mRNAs. The motifs used for this study were identified by a MEME-based analysis of PPS sequences.
Sequences for all of the motifs used in this analysis can be found in Additional file 10. Colors indicate cluster membership as defined by k-means
clustering (k = 5). (B) The most significantly enriched biological processes (and corresponding P value) for target transcripts, where the specified
clusters of motifs identified in (A) are co-bound. MDS, multidimensional scaling; PIP-seq, protein interaction profile sequencing; PPS, protein-protected
site; RBP, RNA-binding protein.
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encoding functionally related proteins.
Disease-linked SNPs correlate with protein-bound
RNA sequences
A growing set of evidence suggests that multiple RNA-level
mechanisms, some of which depend upon RNA–protein
interactions, are the means by which particular single
nucleotide polymorphisms (SNPs) in mRNAs effect human
disease phenotypes [38-41]. In support of this, we found
PPSs to be enriched in disease-associated SNPs from dbSNP
build 137 and the NHGRI GWAS Catalog (Figure 6A).Furthermore, the ratio of synonymous to non-synonymous
SNPs was also significantly higher within PPSs compared
with the expressed transcriptome background (Figure 6B,
P = 9.8 × 10–4), lending further support to the notion that
disruption of RNA–protein interactions underlies the
disease mechanism of the polymorphisms in question.
To verify that disease-related human SNPs can affect
RBP–RNA interactions, we used UV-cross-linking analyses
with 38-nucleotide-long RNA probes containing either the
normal or disease-associated variant at their center. For
these analyses, we focused on two specific SNPs that are
associated with porphyria cutanea tarda and early-onset
Figure 6 Disease-associated SNPs are enriched within PPSs in human transcripts. (A) Enrichment of disease-associated SNPs from dbSNP
build 137 and the NHGRI GWAS Catalog in PPSs versus background. *** denotes P→ 0 and ** denotes P < 0.001 (chi-squared test). (B) Ratio of
synonymous to non-synonymous SNPs in PPSs versus background. ** denotes P < 0.001 (chi-squared test). (C,D) Two examples of disease-related
SNPs found in UROD (C) and PARK7 (D) that overlap with PPSs identified by PIP-seq in HeLa cells using ssRNase treatment (SSase). The screenshots
are from our PIP-seq browser [46]. The UROD and PARK7 SNPs (as indicated in the flagged SNPs track) are used in the analyses shown in (E) and
(F), respectively. A blue line below the transcript model denotes the regions used for the analyses in (E) and (F). (E,F) UV-cross-linking analysis of
normal compared to disease-related SNPs using probes with only the specific base pair substitution, as specified in parentheses next to the
disease label, and protein lysates from HeLa cells. The rs121918066 (E) and rs74315352 (F) SNPs associated with porphyria cutanea tarda and
early-onset Parkinson’s disease, respectively, were used in this analysis. Representative images for three replicate experiments. ** denotes
P < 0.001 (one-tailed t-test). bkgd, background; PIP-seq, protein interaction profile sequencing; PPS, protein-protected site; SNP, single nucleotide
polymorphism; SSase, ssRNase treatment.
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ively) (Additional file 11). We found that both disease-
associated SNPs tested had significant effects on specific
RBP–RNA interactions (P < 0.001) (Figure 6C,D). In fact,
we found that rs121918066 disrupted, while rs74315352
enhanced, specific interactions with an RBP complex. These
findings revealed that disease-associated SNPs that reside
within RBP-binding sites can affect the interaction between
proteins and their target RNAs. In total, these results
suggest that modulation of RBP interactions may be a
significant RNA-level disease mechanism in humans.
Conclusions
In general, the global architecture of RNA–protein inter-
actions within the population of both unprocessed and
mature RNA molecules is still poorly characterized
[1,11,12]. We described a novel RNase-mediated protein
footprint sequencing approach (PIP-seq), which globally
identifies RNA–protein interactions for numerous RBPs
in the human transcriptome with a single experiment
(Figure 1A). Our approach is similar to other recently
published methodologies [27], but in addition to polyA-
containing mature mRNAs we also provide a view of
RNA–protein interaction sites in unprocessed mRNAs
(that is, introns). Additionally, our approach is widely
applicable to all samples and organisms since it is not
dependent on the incorporation of non-natural nucleotides
or UV cross-linking.Analysis of the PPSs uncovered by our approach allowed
us to identify significant levels of known and novel RNA–
protein interaction sites and sequence motifs. By comparing
across cross-linkers and RNases, we demonstrated that
each uncovers specific subsets of protein-bound sequences.
This supports the use of multiple reagents for obtaining a
comprehensive analysis of the protein-bound transcriptome
in eukaryotic organisms.
Using the RNA sequences identified as being protein
bound in the HeLa cell transcriptome by PIP-seq, we
uncovered a large set of putative RBP-binding motifs.
Based on their size and sequence characteristics, it is
likely that many of these motifs correspond to binding
sites for RBPs that interact with target RNAs through
multiple RNA-binding domains or complexes of multiple
RBPs. We used these identified RBP-bound motifs to
investigate the interaction between RBPs within target
mRNAs and offer insights into mRNP organization in
the human transcriptome. This study is one of the first
to examine comprehensively the co-binding by RBPs with
specific target mRNAs. Our findings are an important
resource for investigating the binding of groups of RBPs
to collections of mRNAs encoding proteins functioning in
specific biological processes. These sequences can be used
to identify the interacting proteins so that their effects on
post-transcriptional regulation can be further studied.
Finally, we observed a significant overlap of PPSs with
disease-linked SNPs obtained from two different sources
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validated these results using UV-cross-linking experiments
that demonstrated disease-linked SNPs could disrupt or
enhance RBP–RNA interactions. Thus, determining the
molecular details behind each disease-associated SNP that
affects an RNA–RBP interaction will be an important
future research endeavor. It is also worth noting that our
findings point to the intriguing possibility that PIP-seq
could be used in conjunction with genome-wide association
studies to screen for synonymous mutations that may be
causal via altering of any number of RNA–protein interac-
tions in affected tissues. Such a tool would be extremely
valuable in mechanistic, pharmacogenomic and therapeutic
studies of disease-associated polymorphisms. In summary,
we present a powerful method that will be important for
future studies of RNA–protein interaction site dynamics in




For these experiments, HeLa cells were seeded in 15-cm
standard Corning tissue-culture treated culture dishes
(Sigma, St Louis, MO), grown to 90% confluence (ap-
proximately 18 million cells) in DMEM media (Life
Technologies, San Diego, CA) supplemented with L-
glutamine, 4.5 g/L D-glucose, 10% fetal bovine serum
(FBS (Atlanta Biologics, Atlanta, GA)) and Pen/Strep
(Fisher Scientific, Waltham, MA).
Cross-linking experiments
For formaldehyde cross-linking, a 37% formaldehyde
solution (Sigma, St. Louis, MO) was added drop-wise
with mixing directly to cell culture dishes containing
90% confluent cells to a final concentration of 1% and
incubated at room temperature for 10 minutes. Next,
1 M glycine (Sigma, St Louis, MO) was added to a final
concentration of 125 mM and incubated for an additional
5 minutes with mixing. Then, cells were washed twice
with ice-cold PBS and collected. Finally, cells were pelleted
and frozen until the PIP-seq digestions were performed.
For UV-cross-linking experiments, 90% confluent cells
were washed twice with ice-cold PBS and resuspended
in 5 mL of PBS. Cell culture dishes were placed in a UV
Stratalinker 2400 (Agilent Technologies, New Castle, DE)
with the lid removed and irradiated with UV-C (254 nm)
once at 400 mJ/cm2. The cross-linked cells were collected
by scraping, pelleted and then frozen until used.
PIP-seq library preparation
To begin, we lysed the cell pellets in RIP buffer (25 mM
Tris–HCl, pH = 7.4; 150 mM KCl, 5 mM EDTA, pH = 7.5;
0.5% NP40; 10 μM DTT; 1 tablet protease inhibitors/
10 mL) and ground them manually (850 μl of RIP wasused per 10 million cells). The resulting cell lysate was
treated with RNase-free DNase (Qiagen, Valencia, CA).
Subsequently, these DNA-depleted lysates were split
and treated with either 100 U/mL of a single-stranded
RNase (ssRNase) (RNaseONE (Promega, Madison, WI))
with 200 μg/mL BSA in 1× RNaseONE buffer for 1 hour
at room temperature, or 2.5 U/mL of a double-stranded
RNase (dsRNase) (RNaseV1 (Ambion, Austin, TX)) in
1× RNA structure buffer for 1 hour at 37°C as previ-
ously described [29,30] (see Figure 1A for a schematic
description). The proteins were then denatured and
digested by treatment with 1% SDS and 0.1 mg/mL pro-
teinase K (Roche, Basel, Switzerland) for 15 minutes at
room temperature. We used two cell lysates for these
experiments: one treated with the ssRNase and the other
with dsRNase. For the formaldehyde-cross-linking experi-
ments, proteinase digestion was followed by a 2-hour
incubation at 65°C to reverse the cross-links, whereas for
the UV-cross-linking experiments, RNA was liberated
from protein by retreating the lysates with 1% SDS and
1 mg/mL proteinase K for 30 minutes.
To determine whether nuclease-resistant regions in
RNAs are due to protein binding or specific secondary
structures, we also determined the digestion patterns of
ds- and ssRNases in the absence of bound proteins. To do
this, we performed the identical treatments as described
above except that the cross-linked cellular lysates were
treated with 1% SDS and 0.1 mg/mL proteinase K (Roche,
Basel, Switzerland) and ethanol-precipitated prior to being
treated with the two RNases. In this way, the SDS and
proteinase K solubilized and digested the proteins allow-
ing us to deduce PPSs within all detectable RNAs in the
cells of interest (see Figure 1A for a schematic).
The digested RNA was then isolated using the Qiagen
miRNeasy RNA isolation kit following the manufacturer’s
protocol (Qiagen, Valencia, CA). Finally, the purified RNA
was used as the substrate for strand-specific sequencing
library preparation, as previously described [29,30],
with the exception that we also included DSN library
normalization per the manufacturer’s instructions (Illumina,
San Diego, CA). Briefly, 100 ng of the final library was
denatured at 95°C and then annealed for 5 hours at 68°C.
Next, 2 μl of DSN enzyme (1 U/μl) was used to deplete
the re-annealed duplexes. All of the RNase footprint
libraries (a total of four for each replicate: ss- and dsRNase
treatments, footprint and RNase digestion controls) were
sequenced on an Illumina HiSeq2000 using the standard
protocols for 50-bp single-read sequencing.
Read processing and alignment
PIP-seq reads were first trimmed to remove 3′ sequencing
adapters using cutadapt (version 1.0 with parameters -e
0.06 –O 6 -m 14). The resulting trimmed sequences were
collapsed to unique reads and aligned to the human
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ters –read-mismatches 2 –read-edit-dist 2 –max-multihits
10 –b2-very-sensitive –transcriptome-max-hits 10 –no-
coverage-search –no-novel-juncs). PCR duplicates were
collapsed to single reads for all subsequent analyses.
Identification of PPSs
PPSs were identified using a modified version of the CSAR
software package [34]. Specifically, read coverage values
were calculated for each base position in the genome and
a Poisson test was used to compute an enrichment score
for footprint versus RNase digestion control libraries. PPSs
were then called as described [34] with an FDR of 5%.
PPS saturation analysis
Mapped reads from chromosome 9 of formaldehyde-
cross-linked ssRNase-treated PIP-seq replicate 1 libraries
were randomly subsampled at 10% to 90% by a custom
Perl script. CSAR was used to identify PPSs as described
and the total number of PPSs was plotted as a function of
subsample size.
Validation by comparison with CLIP-seq, PAR-CLIP
and gPAR-CLIP data
iCLIP, PAR-CLIP, and CLIP-seq datasets were compiled
from sources as referenced and overlapped with PPSs. The
significance of overlaps with PPSs was assessed using a
chi-squared test compared to an expressed transcriptome
background. To compute a background distribution for
the number of T > C transversions, we generated ten ran-
dom sets of genomic intervals with the same size distri-
bution as PPSs. These random intervals were selected
from a background of actively transcribed regions (defined
using bgrSegmenter [43] with parameters: threshold = 10,
maxGap = 10 and minRun = 15).
Functional analysis of PPSs
Gene annotations were downloaded from the UCSC Gen-
ome Browser (RefSeq Genes, wgRna, rnaGene, lncRNA),
and miRBase release 18 was used for the microRNA
annotations. PPS annotation was done ‘greedily’, such that
all functional annotations that overlapped with a given
PPS were counted equally. Conservation was assessed by
computing average SiPhy-π log-odds [44] scores within
PPSs and in equal-sized regions immediately upstream
and downstream of each PPS.
Motif and co-occurrence analysis
MEME [35] was used to identify enriched RBP interaction
motifs with parameters –dna –nmotifs 100 –evt 0.01 –
maxsize 100000000. Motif co-occurrence was defined at
the transcript level, and k-means clustering of the resultant
weighted adjacency matrix was used to identify modules
of co-occurring motifs. We set k = 5 based on manualinspection of clusters on a multidimensional scaling (MDS)
plot of the adjacency matrix. GO analysis was performed
using DAVID [37].
Analysis of SNPs and disease associations
Clinically associated SNPs (snp137Flagged) were down-
loaded from the UCSC Table Browser. We also down-
loaded the NHGRI GWAS Catalog [42] of disease-linked
SNPs. Background distributions refer to the incidence of
each dataset within the same genic regions as those of the
PPSs in each analysis. Significance was assessed using a
chi-squared test.
UV-cross-linking analysis of disease-associated SNPs
We generated asymmetric oligonucleotide hybrids for
in vitro transcription by annealing T7 sense DNA oligonu-
cleotides (TAATACGACTCACTATAGGG) to antisense
probe sequences fused to the antisense T7 (aT7) sequence
(rs74315352 normal: CTTGTAAGAATCAGGCCGtCTT
TTTCCACACGATTCTC(aT7), rs74315352 disease: CTT
GTAAGAATCAGGCCGgCTTTTTCCACACGATTCTC
(aT7), rs121918066 normal: CCCAGGTTGGCAATGTA
GcGATGTGGTCCAAAGTCATC(aT7), rs121918066 dis-
ease: CCCAGGTTGGCAATGTAGtGATGTGGTCCAA
AGTCATC(aT7)) (IDT, San Jose, CA). Each hybrid reaction
was incubated at 95°C for 5 minutes and cooled to 25°C
by step-wise increments of 1°C/minute.
In vitro transcription reactions were performed by
adding 1 μg of the asymmetric oligonucleotide hybrids
(see above) to a 25 μL transcription reaction comprising
1× T7 RNA Transcription buffer (NEB, Cambridge, MA),
36 μM uridine triphosphate (UTP) (for rs74315352) or
36 μM cytidine triphosphate (CTP) (for rs121918066),
264 μM each of ATP, CTP and guanosine triphosphate
(GTP) (for rs74315352) or 264 μM each of ATP, UTP
and GTP (for rs121918066), 0.04 mCi 32P UTP (for
rs74315352) or 0.04 mCi 32P CTP (for rs121918066),
10 nM DTT, 40 U RNaseOUT (Invitroge, Carlsbad, CA),
and 75 U of T7 RNA polymerase. The reactions were
incubated at 37°C for 2 hours. DNA was digested with
four units of Turbo DNase (Invitrogen, Carlsbad, CA)
at 37°C for 20 minutes. RNA probes were chloroform-
extracted and precipitated. The amount of a labeled RNA
probe was determined by 15% TBE-urea gel electrophoresis
followed by phosphor-imaging and densitometry. Normal
and disease RNA probes were normalized to equal activities
and used for subsequent analysis.
Equal concentrations of each RNA probe (approximately
10% of the total from in vitro transcription) were added to
separate 10.2 μL binding reactions comprising 0.2 mM
Tris pH 7.5, 0.02 mM EDTA, 40 mM KCl, 1.3% polyvinyl
alcohol, 25 ng/μl tRNA, 3 mM MgCl2, 1 mM ATP,
50 mM creatine phosphate and 1.5 μg/μl HeLa whole cell
lysate in RIP buffer (25 mM Tris–HCl, pH = 7.4; 150 mM
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tablet protease inhibitors/10 mL) and incubated at 30°C
for 20 minutes. The binding reaction was then subjected
to UV cross-linking for 20 minutes using a 254-nm UV
lamp (Mineralight Lamp Model R-52G (UVP, Upland,
CA)). To digest unbound RNA, each reaction was incu-
bated with 20 U RNase T1 and 8 μg RNase A at 37°C
for 20 minutes. RNA-bound proteins were denatured
in 1× SDS sample buffer and 1 mM β-mercaptoethanol
and boiled for 5 minutes. Samples were separated on
NuPAGE 3% to 8% Tris-acetate gel (Invitrogen, Carlsbad,
CA) at 130 V for 1.5 hrs. Phosphor-imaging and densitom-
etry were used to visualize and quantify protein-bound
RNA, respectively.Accession numbers
All PIP-seq data from our analyses were deposited in GEO
under the accession GSE49309. All of our data (files of all
identified PPSs, complete lists of overrepresented motifs,
GO analyses and so on) can also be accessed at [45]. The
web browsers used for visualization of all PPSs and our
analyzed and raw sequencing data can be found at [46] for
jbrowse and at [47] for the UCSC genome browser.Additional files
Additional file 1: PIP-seq library characteristics. Information on PIP-seq
libraries, including sequencing reads, processing, mapping and PPS
identification.
Additional file 2: PIP-seq reveals protein-binding sites throughout
the human transcriptome (related to Figure 1). (A,B,C,D,E) Screenshots
show PIP-seq reads for the formaldehyde-cross-linked ssRNase-treated
footprint (top sequencing track) and RNase digestion control libraries
(bottom sequencing track). Blocks indicate regions identified as PPSs in
each of the three replicates. Chromosomal coordinates, UCSC gene tracks
(including alternative events), and PhyloP conservation scores are
included (as labeled). The screenshots are from our PIP-seq browser [47].
Examples include four protein-coding genes (A to D) and an lncRNA
gene (E). (F) Number of PPSs identified in subsets of total reads from
human chromosome 9 for the formaldehyde-cross-linked ssRNase-treated
libraries.
Additional file 3: Summary statistics for PPSs identified by
UV-cross-linked and non-cross-linked experiments (related to Figure 1).
(A) Absolute distribution of PPSs throughout RNA species identified using
no cross-linking. (B) Average PPS count per RNA molecule (classified by
type (mRNA and lncRNA) and transcript region (for example, 5′ UTR))
identified using no cross-linking. Percentages indicate the fraction of each
RNA type or region that contains PPS information. (C) Average expression
(y-axis) of human mRNAs separated by total number of PPSs identified in
their sequence (x-axis) for UV-cross-linked experiments. (D) As (C), but for
PPSs identified using no cross-linking.
Additional file 4: Correlation of PIP-seq read counts (related to
Figure 2). Correlation in read counts between additional formaldehyde-
(A and B) and UV-cross-linked (C) PIP-seq replicates as labeled.
Additional file 5: PIP-seq is a reproducible approach (related to
Figure 2). (A) Overlap in PPS calls between additional formaldehyde-
cross-linked ssRNase-treated (blue) and dsRNase-treated (green) PIP-seq
replicates. (B) Overlap in PPS calls between two replicates of UV-cross-linked
ssRNase-treated (blue) and dsRNase-treated (green) PIP-seq replicates. (C)
Overlap in PPS calls between formaldehyde-cross-linked ssRNase-treatedand dsRNase-treated PIP-seq samples. (D – E) As (C), but for UV-cross-linked
replicates (D) and the non-cross-linked experiment (E).
Additional file 6: Validation of PIP-seq by comparison with previously
published RBP binding site datasets. (A) Overlap between PPSs identified
from two UV-cross-linked PIP-seq samples and various CLIP datasets. Values
are shown as log2 enrichment over shuffled background distributions. (B) As
(A), but for a non-cross-linked PIP-seq sample. *** denotes P < 2.2 × 10-16
(chi-squared test). (C) Overlap between UV-cross-linked PPSs and 40-
nucleotide T > C transversion event-containing loci from the gPAR-CLIP
dataset (T > C transversion events less than 40 bp apart were merged to
generate a dataset comparable to PPSs). (D) As (C), but for PPSs identified
with no cross-linking. (E) Number of T > C transversion events per PPS
identified using UV cross-linking (magenta) versus shuffled regions (gray).
Values for the number of events per shuffled region are the average from
ten random shuffles. (F) As (E), but for PPSs identified with no cross-linking.
Additional file 7: Characterization of PPSs identified by
UV-cross-linking and no-cross-linking PIP-seq experiments
(related to Figure 3). (A) Distribution of ssRNase-treated (blue) and
dsRNase-treated (green) PPS sizes from UV-cross-linked samples.
Dashed lines represent mean PPS sizes (ssRNase, blue line and
dsRNase, green line). (B) As (A), but for non-cross-linked PPSs. (C)
Genomic distribution of UV-cross-linked PPS density, measured as PPS
base coverage normalized to RNase digestion control read counts per
genomic region. Proximal intron refers to 500 nucleotides at the 5′
and 3′ ends of introns. (D) As (C), but for non-cross-linked PPSs. (E)
Fraction of base pairs covered by PPSs in 100 most highly expressed
lncRNAs (orange bars) and expression-matched control mRNA 3′ UTRs
(purple bars) for PIP-seq libraries made with ssRNase (ss) or dsRNase
(ds) under the three different cross-linking conditions (as specified).
Additional file 8: PPSs identified by UV-cross-linking and
no-cross-linking PIP-seq experiments are evolutionarily conserved
(related to Figure 3). (A,B) Cumulative distribution of average SiPhy-π
scores in PPSs identified by UV cross-linking (A) and no cross-linking (B).
PPSs (red) are compared to flanking sequences (gray). (C,D) Comparison
of average SiPhy-π scores between PPSs identified by UV cross-linking (C)
and no cross-linking (D). PPSs (red) are compared to flanking sequences
(gray) for various genomic regions. (E,F) Average SiPhy-π score profiles
across the first and last 25 nucleotides of PPSs identified by UV cross-
linking (E) and no cross-linking (F), as well as 50 nucleotides upstream
and downstream of exonic (green line), intronic (blue line) and lncRNA
(orange line) PPSs. *** denotes P < 2.2 × 10–16 (chi-squared test). NS, not
significant.
Additional file 9: Genomic distribution of PPSs identified by
UV-cross-linking and no-cross-linking PIP-seq experiments
(related to Figure 4). (A) Average PPS density for no-cross-linking PIP-seq
across 100 equally spaced bins in various genic regions. Values are
normalized separately for each genic region (for example, intron). (B)
Average PPS density for no-cross-linking PIP-seq within 50 nucleotides
of CDS ends. (C) Average PPS density for no-cross-linking PIP-seq
within the first and last 50 nucleotides of introns. Dotted lines in (B,C)
represent the remaining (unanalyzed) length of each element.
Additional file 10: Motif and co-occurrence analyses. Motifs identified
by MEME analyses of PPS sequences from specific subregions of
protein-coding mRNAs. Those motifs used in the co-occurrence analyses
(Figure 5) are listed in this table.
Additional file 11: Table of disease-associated SNPs that overlap
with PPSs. Information on all flagged and GWAS SNPs overlapping PPSs
identified using formaldehyde-cross-linked PIP-seq.Abbreviations
bp: Base pair; BSA: Bovine serum albumin; CDS: Coding sequence;
CLIP-seq: Cross-linking and immunoprecipitation sequencing; CTP: Cytidine
triphosphate; DSN: Duplex-specific nuclease; dsRNA: Double-stranded RNA;
dsRNase: Double-stranded RNase; FDR: False discovery rate; GO: Gene
ontology; gPAR-CLIP: Global photoactivatable ribonucleoside cross-linking
and immunoprecipitation; GTP: Guanosine triphosphate; lncRNA: Long
non-coding RNA; MDS: Multidimensional scaling; mRNA: Messenger RNA;
ncRNA: Non-coding RNA; NS: Not significant; PAR-CLIP: Photoactivatable
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sequencing; polyA: Poly-adenylated; PPS: Protein-protected site; RBD:
RNA-binding domain; RBP: RNA-binding protein; RNase: Ribonuclease;
RNP: Ribonucleoprotein complex; SNP: Single nucleotide polymorphism;
ssRNA: Single-stranded RNA; ssRNase: Single-stranded RNase; UTP: Uridine
triphosphate; UTR: Untranslated region.
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